Prevention of the serotonin reuptake inhibitor discontinuation syndrome

Medical Hypotheses

Volumn 59, Issue 1, 2002, Pages 92-94

  Sher, Leo ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANXIETY NEUROSIS; ARTICLE; BIOEQUIVALENCE; BREAST FEEDING; CONGENITAL DRUG DEPENDENCE; DOSE RESPONSE; DRUG WITHDRAWAL; HUMAN; MEDICAL DECISION MAKING; MEDICAL EDUCATION; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOTHERAPY; SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME;

EID: 0036655971     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(02)00127-5     Document Type: Article

References (26)

1. Antidepressant discontinuation syndromes: Clinical relevance, prevention and management
2. Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial
3. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: A literature review
4. Selective serotonin reuptake inhibitor discontinuation syndrome: Proposed diagnostic criteria
5. Physical symptoms associated with paroxetine discontinuation
6. Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine
7. Paroxetine in the treatment of panic disorder: A randomised, double-blind, placebo-controlled study
8. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition
9. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome
10. Selective serotonin reuptake inhibitors and discontinuation symptoms
11. Mood disorders: Psychotherapy
12. Psychotherapy for the treatment of depression: A comprehensive review of controlled outcome research
13. Anxiety disorders: Psychological treatments
14. Behavioral psychotherapy for anxiety disorders
15. Diagnosis and treatment of seasonal affective disorder
16. Seasonal affective disorder and seasonality: A review
17. Light treatment for nonseasonal depression: Speed, efficacy, and combined treatment
18. Other pharmacological and biological therapies
19. Clinical management of antidepressant discontinuation
20. Generic medicine - Can quality be assured?
21. Controlled withdrawal for psychotropic drugs
22. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
23. An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram
24. Withdrawal reactions associated with venlafaxine
25. Discontinuation symptoms with nefazodone
26. Candidate gene studies in psychiatric disorders: Promises and limitations